使用基于多鲁曲韦治疗方案的艾滋病病毒感染者的病毒学抑制、不依从性及相关因素:回顾性队列研究

Florence Kabiibi, Robert Tamukong, Winnie Muyindike, Tadele Yadesa
{"title":"使用基于多鲁曲韦治疗方案的艾滋病病毒感染者的病毒学抑制、不依从性及相关因素:回顾性队列研究","authors":"Florence Kabiibi, Robert Tamukong, Winnie Muyindike, Tadele Yadesa","doi":"10.2147/hiv.s449947","DOIUrl":null,"url":null,"abstract":"Background: HIV is one of the leading causes of morbidity and mortality, with 39.0 million people living with HIV worldwide, 25.6 million of whom reside in the African region. Highly active anti-retroviral therapy (HAART) has improved survival and quality of life, yet some patients develop viral non-suppression. Dolutegravir (DTG) has been recommended since 2018 as a first-line treatment option in low-and middle-income countries owing to its effectiveness, low cost, and tolerability, but some studies have reported virological non-suppression with its use. This study aims to explore the prevalence and factors associated with virological non-suppression in adults taking DTG-based regimens in Mbarara Regional Referral Hospital. Methods: A retrospective cohort study was carried out among people living with HIV (PLWHIV) taking DTG-based HAART regimens by way of record review. SPSS was used for analysis, and both binary and multivariate logistic regression analyses were performed to test associated factors. Results: Among the 422 participants’ records reviewed, 62.8% were female (median age 40 years, IQR=13). The prevalence of virological non-suppression was 4.2%. Poor adherence to HAART was significantly associated with virological non-suppression, with 100.3 increased adjusted odds (95% CI: 28.90–348.12, p <0.001) compared to those with a record of good adherence. The reasons for poor adherence included alcohol use, stigma, forgetting to take medication, transport problems, and irregular timing of swallowing. Conclusion: This study found poor adherence to be associated with a 4.2% prevalence of virological non-suppression among PLWHIV in a large public HIV care clinic. Despite the high suppression rates on DTG-based regimens, adherence counseling and viral load monitoring need to be emphasized at all HIV care centers to mark the trends of virological non-suppression.","PeriodicalId":504538,"journal":{"name":"HIV/AIDS - Research and Palliative Care","volume":"23 22","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Virological Non-Suppression, Non-Adherence and the Associated Factors Among People Living with HIV on Dolutegravir-Based Regimens: A Retrospective Cohort Study\",\"authors\":\"Florence Kabiibi, Robert Tamukong, Winnie Muyindike, Tadele Yadesa\",\"doi\":\"10.2147/hiv.s449947\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: HIV is one of the leading causes of morbidity and mortality, with 39.0 million people living with HIV worldwide, 25.6 million of whom reside in the African region. Highly active anti-retroviral therapy (HAART) has improved survival and quality of life, yet some patients develop viral non-suppression. Dolutegravir (DTG) has been recommended since 2018 as a first-line treatment option in low-and middle-income countries owing to its effectiveness, low cost, and tolerability, but some studies have reported virological non-suppression with its use. This study aims to explore the prevalence and factors associated with virological non-suppression in adults taking DTG-based regimens in Mbarara Regional Referral Hospital. Methods: A retrospective cohort study was carried out among people living with HIV (PLWHIV) taking DTG-based HAART regimens by way of record review. SPSS was used for analysis, and both binary and multivariate logistic regression analyses were performed to test associated factors. Results: Among the 422 participants’ records reviewed, 62.8% were female (median age 40 years, IQR=13). The prevalence of virological non-suppression was 4.2%. Poor adherence to HAART was significantly associated with virological non-suppression, with 100.3 increased adjusted odds (95% CI: 28.90–348.12, p <0.001) compared to those with a record of good adherence. The reasons for poor adherence included alcohol use, stigma, forgetting to take medication, transport problems, and irregular timing of swallowing. Conclusion: This study found poor adherence to be associated with a 4.2% prevalence of virological non-suppression among PLWHIV in a large public HIV care clinic. Despite the high suppression rates on DTG-based regimens, adherence counseling and viral load monitoring need to be emphasized at all HIV care centers to mark the trends of virological non-suppression.\",\"PeriodicalId\":504538,\"journal\":{\"name\":\"HIV/AIDS - Research and Palliative Care\",\"volume\":\"23 22\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV/AIDS - Research and Palliative Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/hiv.s449947\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV/AIDS - Research and Palliative Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/hiv.s449947","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:艾滋病毒是发病和死亡的主要原因之一,全球有 3,900 万艾滋病毒感染者,其中 2,560 万人居住在非洲地区。高活性抗逆转录病毒疗法(HAART)提高了患者的生存率和生活质量,但仍有一些患者出现病毒抑制。多罗替拉韦(DTG)由于疗效好、成本低、耐受性强,自2018年起被推荐作为中低收入国家的一线治疗方案,但一些研究报告称使用该药物后出现病毒学抑制。本研究旨在探讨姆巴拉拉地区转诊医院中服用基于 DTG 方案的成人病毒学抑制的发生率和相关因素。研究方法通过查阅记录,对服用基于 DTG 的 HAART 方案的艾滋病病毒感染者(PLWHIV)进行了一项回顾性队列研究。使用 SPSS 进行分析,并通过二元和多变量逻辑回归分析来检验相关因素。结果在查阅的 422 名参与者的记录中,62.8% 为女性(中位年龄为 40 岁,IQR=13)。病毒学抑制的发生率为 4.2%。对 HAART 的依从性差与病毒学抑制明显相关,与依从性好的患者相比,调整后的几率增加了 100.3(95% CI:28.90-348.12,p <0.001)。依从性差的原因包括酗酒、耻辱感、忘记服药、交通问题和吞咽时间不规律。结论这项研究发现,在一家大型公立艾滋病护理诊所中,依从性差与艾滋病毒感染者中 4.2% 的病毒学抑制率有关。尽管以 DTG 为基础的治疗方案的病毒抑制率很高,但所有艾滋病护理中心都需要重视依从性咨询和病毒载量监测,以确定病毒学抑制的趋势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Virological Non-Suppression, Non-Adherence and the Associated Factors Among People Living with HIV on Dolutegravir-Based Regimens: A Retrospective Cohort Study
Background: HIV is one of the leading causes of morbidity and mortality, with 39.0 million people living with HIV worldwide, 25.6 million of whom reside in the African region. Highly active anti-retroviral therapy (HAART) has improved survival and quality of life, yet some patients develop viral non-suppression. Dolutegravir (DTG) has been recommended since 2018 as a first-line treatment option in low-and middle-income countries owing to its effectiveness, low cost, and tolerability, but some studies have reported virological non-suppression with its use. This study aims to explore the prevalence and factors associated with virological non-suppression in adults taking DTG-based regimens in Mbarara Regional Referral Hospital. Methods: A retrospective cohort study was carried out among people living with HIV (PLWHIV) taking DTG-based HAART regimens by way of record review. SPSS was used for analysis, and both binary and multivariate logistic regression analyses were performed to test associated factors. Results: Among the 422 participants’ records reviewed, 62.8% were female (median age 40 years, IQR=13). The prevalence of virological non-suppression was 4.2%. Poor adherence to HAART was significantly associated with virological non-suppression, with 100.3 increased adjusted odds (95% CI: 28.90–348.12, p <0.001) compared to those with a record of good adherence. The reasons for poor adherence included alcohol use, stigma, forgetting to take medication, transport problems, and irregular timing of swallowing. Conclusion: This study found poor adherence to be associated with a 4.2% prevalence of virological non-suppression among PLWHIV in a large public HIV care clinic. Despite the high suppression rates on DTG-based regimens, adherence counseling and viral load monitoring need to be emphasized at all HIV care centers to mark the trends of virological non-suppression.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信